Antreas Charidimou, MD, PhD, MSc, FESO Receives $9M Grant from Leducq Foundation
Photo by Shubham Dhage on Unsplash.
Grant Award
Antreas Charidimou, MD, PhD, MSc, FESO,
Receives $9M Grant from Leducq Foundation
Research focuses on detection and diagnosis process for cerebral amyloid angiopathy.
Antreas Charidimou, MD, PhD, MSc, FESO, is part of a research team to receive the Leducq Foundation’s International Networks of Excellence Program award. This $9 million grant will support research on the “Translational Framework For Innovation in Cerebral amyloid angiopathy (TRAFFIC).“
The goal of this research is to improve the detection and diagnosis process for cerebral amyloid angiopathy (CAA), a condition that causes brain bleeds and cognitive decline, often contributing to dementia.
Andreas Charidimou, MD, PhD, MSc, FESOCharidimou is an assistant professor of neurology at Boston University Chobanian & Avedisian School of Medicine and the assistant medical director for the BU Center for Brain Recovery. He will co-lead the project with his international collaborator Marcel Verbeek, PhD, MSc, from Radboud University Medical Center (Netherlands). BU is the leading coordinating center.
The goal of this research is to improve the detection and diagnosis process for cerebral amyloid angiopathy (CAA), a condition that causes brain bleeds and cognitive decline, often contributing to dementia. The researchers will combine advanced brain imaging and new molecular biomarkers to improve earlier detection, while also training the next generation of CAA scientists through mentorship and funding. Learn more about the project here.